Related Experiment Video
Updated: Oct 4, 2025

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Children who stroke on VAD support: When is it safe to transplant and what are their outcomes?
Karthik Thangappan1, Li Cai Haney1, Kyle Riggs2
1Department of Cardiothoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Insights
Pediatric heart transplant candidates who experience a stroke while on a ventricular assist device (VAD) have similar post-transplant survival rates compared to those without a stroke. Further research is needed to determine the optimal time between stroke and transplantation for improved outcomes.
Area of Science:
- Pediatric Cardiology
- Transplantation Medicine
- Neurology
Background:
- Ventricular assist devices (VADs) improve survival for pediatric heart transplant candidates.
- Stroke remains a significant risk for patients on VAD support.
- Understanding the impact of pre-transplant stroke on post-transplant outcomes is crucial.
Purpose of the Study:
- To analyze the impact of strokes occurring during VAD support on post-heart transplant outcomes in children.
- To compare survival rates and other outcomes between pediatric patients with and without pre-transplant strokes on VADs.
Main Methods:
- A retrospective analysis of 520 pediatric heart transplant candidates (<18 years) who received a VAD between January 2011 and April 2018.
- Data were matched between the United Network of Organ Sharing and Pediatric Health Information System databases.
- Patients were categorized into pre-transplant stroke and no-stroke cohorts.
Main Results:
- 81% of patients were transplanted; 28% experienced a pre-transplant stroke.
- Patients with stroke were transplanted later (median 57 days) compared to the no-stroke cohort (significantly higher transplant rate in no-stroke group).
- No significant difference in post-transplant survival was observed between the stroke and no-stroke groups (p=0.440). Patients transplanted >60 days post-stroke had comparable survival to no-stroke patients.
Conclusions:
- Pediatric patients transplanted after experiencing a stroke on VAD support demonstrate similar long-term survival to those without a stroke.
- Allowing a longer recovery period after stroke before transplantation may potentially improve outcomes, though optimal timing remains undetermined.
- Larger, more detailed studies are required to establish the ideal interval between stroke and heart transplantation.
Objective:
Ventricular assist devices (VADs) increase waitlist survival, yet the risk of stroke remains notable. The purpose of this study was to analyze how strokes on VAD support impact post-transplant (post-Tx) outcomes in children.
Methods:
About 520 pediatric (<18 years) heart transplant candidates listed from January 2011 to April 2018 with a VAD implant date were matched between the United Network of Organ Sharing and Pediatric Health Information System databases. Patients were divided into pre-Tx Stroke and No Stroke cohorts.
Results:
About 81% of the 520 patients were transplanted; 28% (n = 146) had a pre-Tx Stroke; and 59% (n = 89) of the Stroke patients were transplanted at a median of 57 (IQR 17-102) days from stroke. Significantly more No Stroke cohort (90%) were transplanted (p < 0.001). There was no difference in post-Tx survival between the Stroke and No Stroke cohorts (p = 0.440). Time between stroke and transplant for patients who died within 1 year of transplant was 32.0 days (median) compared to 60.5 days for those alive >1 year (p = 0.18). Regarding patients in whom time from stroke to transplant was more than 60 days, one-year survival of Stroke vs. No Stroke patients was 96% vs. 95% (p = 0.811), respectively.
Conclusion:
Patients with stroke during VAD support, once transplanted, enjoy similar survival compared to No Stroke patients. We hypothesize that allowing Stroke patients more time to recover could improve post-Tx outcomes. Unfortunately, the ideal duration of time between stroke and safe transplantation could not be determined and will require more detailed and larger studies in the future.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy V: Interprofessional Care
Kidney Transplant I: Introduction
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Kidney Transplant III: Nursing Management

